So, unblinding on the 12th. Company reviews and makes determination for EUA filing. If/when FDA reports back, company has 4 days to disclose.
I think NP has already stated they would release unblinded data on the 14th. If primary endpoint is met, it’s clear what the end result will be. Only way to catch shorts here is for NP to not publicly release unblinded data. Keeps people guessing on what the feedback would be for EUA request